Antonella Chillemi
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors.
Journal: Frontiers in pharmacology
Published: November 17, 2017
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.
Journal: Molecular medicine (Cambridge, Mass.)
Published: May 15, 2017
Antibody mimicry, receptors and clinical applications.
Journal: Human antibodies
Published: December 31, 2016
Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche.
Journal: Frontiers in immunology
Published: December 16, 2016
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation.
Journal: Oncotarget
Published: October 27, 2016
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.
Journal: Oncogene
Published: October 20, 2016
Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates with Progression of Human Myeloma.
Journal: Molecular medicine (Cambridge, Mass.)
Published: September 22, 2016
Extracellular Antibody Drug Conjugates Exploiting the Proximity of Two Proteins.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 08, 2016
NAD⁺-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma Model.
Journal: Cells
Published: August 04, 2015
CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 11, 2015
Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche.
Journal: Annals of the New York Academy of Sciences
Published: July 23, 2014
Last Updated: 09/26/2026